- Details
Retrospective review shows anti-VEGF treatment should be performed cautiously in patients with retinal angiomatous proliferation (RAP).
Read more: Risk factors for RPE tears after ranibizumab for RAP
- Details
Embattled drugmaker Valeant Pharmaceuticals has struck a deal with Walgreens to distribute some of its drugs at a 10% discount.
- Details
Mundipharma and Purdue Pharma Canada have acquired marketing rights to Merck’s glaucoma portfolio outside of the United States.
Read more: Merck continues to divest its ophthalmology products
- Details
Cellceutix Corporation announced that the U.S. FDA granted rare pediatric disease designation to kevetrin for the treatment of retinoblastoma.
Read more: Retinoblastoma drug granted rare pediatric disease designation
- Details
Communicating with patients using cap color exclusively could lead to confusion and harm, especially when treating patients with more advanced disease.
- Details
A retrospective study found that a commonly prescribed drug for Parkinson’s, L-DOPA, may delay or prevent AMD.